aromatas
inhibitor
import
target
treatment
estrogendepend
cancer
order
search
potent
steroid
aromatas
inhibitor
sai
lower
side
effect
overcom
cellular
resist
compar
molecular
field
analysi
comfa
compar
molecular
similar
indic
analysi
comsia
perform
seri
sai
build
qsar
model
reliabl
predict
comfa
comsia
model
obtain
statist
result
comfa
q
r
ncv
r
pred
comsia
q
r
ncv
r
pred
qsar
approach
provid
signific
insight
use
develop
novel
potent
sai
addit
genet
algorithm
linear
assign
hypermolecular
align
databas
galahad
use
deriv
pharmacophor
model
select
pharmacophor
model
contain
two
acceptor
atom
four
hydrophob
center
use
queri
virtual
screen
databas
six
hit
compound
obtain
biolog
activ
predict
comfa
comsia
model
expect
design
potent
novel
sai
aromatas
cytochrom
depend
enzym
catalyz
aromat
androgen
estrogen
aromatas
inhibitor
ai
reduc
synthesi
estrogen
offer
therapeut
altern
treatment
estrogendepend
cancer
breast
cancer
two
class
ai
steroid
nonsteroid
compound
caus
potent
estrogen
suppress
nonsteroid
aromatas
inhibitor
nsai
mostli
azol
type
compound
clinic
use
anastrozol
letrozol
compet
substrat
bind
enzym
activ
site
among
steroid
aromatas
inhibitor
sai
formestan
wide
use
earli
use
nowaday
need
administ
intramuscular
inject
therefor
oral
activ
exemestan
main
steroid
inhibitor
sai
mimic
natur
substrat
androstenedion
convert
enzym
reactiv
intermedi
bind
irrevers
enzym
activ
site
result
inactiv
aromatas
despit
success
thirdgener
nsai
anastrazol
letrozol
sai
exemestan
still
major
side
effect
increas
bone
loss
joint
pain
heart
problem
addit
year
usag
develop
cellular
resist
reason
import
search
potent
specif
molecul
lower
side
effect
overcom
resist
phenomena
quantit
structureact
relationship
qsar
method
success
employ
assist
design
new
small
molecul
drug
candid
compar
molecular
field
analysi
comfa
compar
molecular
similar
indic
analysi
comsia
two
wide
use
threedimension
quantit
structureact
relationship
qsar
methodolog
comfa
calcul
energi
steric
electrostat
interact
compound
probe
atom
variou
intersect
regular
lattic
accord
lennardjon
coulomb
potenti
result
energi
deriv
two
potenti
function
contour
offer
quantit
spatial
descript
molecular
properti
comsia
introduc
gaussian
function
distanc
depend
molecular
atom
probe
atom
order
avoid
inher
defici
aris
lennardjon
coulomb
potenti
function
form
comsia
appli
gain
insight
steric
field
electrostat
field
hydrophob
field
hydrogen
bond
donor
hbd
hydrogen
bond
acceptor
hba
influenc
activ
inhibitor
pharmacophor
model
provid
valuabl
insight
ligandreceptor
interact
pharmacophor
search
best
option
find
rang
chemic
structur
viabl
featur
pharmacophor
model
consid
ensembl
steric
electrostat
featur
differ
compound
necessari
ensur
optim
supramolecular
interact
specif
biolog
target
structur
trigger
block
biolog
respons
thu
pharmacophor
model
method
choic
first
round
compound
select
abil
pharmacophor
model
use
find
new
class
inhibitor
one
class
known
known
scaffold
hop
seri
sai
shown
tabl
report
recent
literatur
understand
structur
requir
inhibitori
activ
design
potent
agent
qsar
studi
perform
fist
time
sai
use
comfa
comsia
addit
pharmacophor
model
creat
select
best
model
use
queri
virtual
screen
databas
biolog
activ
hit
compound
predict
use
comfa
comsia
model
statist
paramet
standard
comfa
model
construct
steric
electrostat
field
given
tabl
crossvalid
coeffici
q
r
cv
noncrossvalid
correl
coeffici
r
ncv
standard
error
estim
see
fstatist
valu
f
comput
defin
sybyl
crossvalid
leaveoneout
pl
analysi
show
q
valu
ten
compon
noncrossvalid
pl
analysi
result
r
ncv
see
f
valu
indic
model
high
qualiti
correspond
field
contribut
steric
electrostat
respect
mean
steric
field
give
contribut
bioactiv
electrostat
field
commonli
comsia
five
differ
similar
field
steric
electrostat
hydrophob
hbd
hba
calcul
howev
comsia
model
model
global
descriptor
best
model
probabl
paper
discuss
whether
five
differ
descriptor
field
comsia
total
independ
depend
individu
field
usual
decreas
signaltonois
ratio
data
lower
statist
signific
result
therefor
studi
optim
possibl
combin
five
differ
descriptor
field
evalu
valu
q
shown
figur
higher
valu
q
show
better
model
highest
q
comsia
model
combin
steric
hba
field
sa
final
chosen
best
model
indic
steric
hba
field
mainli
contribut
bind
affin
comsia
sa
model
obtain
seventeen
optim
compon
analysi
result
summar
tabl
q
r
ncv
f
see
correspond
field
contribut
steric
hba
respect
mean
steric
field
provid
bioactiv
contribut
hba
field
order
valid
obtain
qsar
model
r
pred
use
determin
predict
abil
comfa
comsia
model
compound
test
set
includ
gener
model
obtain
r
pred
test
set
comfa
comsia
model
respect
indic
model
good
predict
abil
observ
predict
train
test
set
comfa
comsia
model
list
tabl
correl
observ
predict
train
test
set
depict
figur
comfa
model
figur
comsia
model
respect
observ
pic
predict
steric
contour
map
comfa
model
activ
inhibitor
compound
shown
figur
green
contour
repres
region
high
steric
bulk
toler
contribut
yellow
contour
repres
region
low
steric
bulk
toler
contribut
seen
larg
green
contour
near
ring
b
indic
bulki
group
posit
favor
bioactiv
support
higher
activ
compound
larg
substitu
posit
compar
lower
activ
compound
small
substitu
posit
also
observ
two
larg
yellow
contour
one
next
ring
anoth
near
ring
suggest
bulki
group
two
region
decreas
inhibitori
activ
confirm
fact
compound
bulki
substitut
ring
lower
bioactiv
compound
small
substitut
posit
compound
bulki
group
near
ring
compound
compound
show
low
bioactiv
comfa
electrostat
contour
map
shown
figur
red
area
region
neg
potenti
favor
activ
neg
potenti
unfavor
blue
area
figur
display
two
red
contour
around
ring
one
red
contour
near
ring
mean
bioactiv
enhanc
electroneg
atom
present
area
support
studi
compound
electroneg
atom
ring
addit
also
confirm
fact
compound
oxygen
atom
show
higher
activ
compound
oxygen
atom
posit
respect
steric
hba
field
shown
figur
field
favor
disfavor
contour
repres
level
contribut
respect
figur
show
steric
contour
map
comsia
model
activ
inhibitor
compound
green
region
steric
favor
yellow
region
steric
unfavor
clear
distribut
steric
field
comsia
basic
consist
comfa
result
littl
differ
yellow
contour
larg
green
contour
indic
proper
bulki
substitu
ring
b
favor
bioactiv
larg
substitu
posit
unfavor
support
case
inhibitori
activ
compound
declin
augment
substitu
ring
b
figur
show
hba
contour
map
magenta
red
contour
repres
area
hba
substitu
favor
disfavor
respect
magenta
contour
figur
one
next
ring
anoth
near
ring
third
one
close
ring
indic
activ
enhanc
hba
atom
present
posit
also
consist
distribut
electrostat
field
comfa
support
case
studi
compound
least
one
hba
atom
posit
also
confirm
exampl
compound
formestan
show
quit
high
bioactiv
three
hba
atom
posit
twenti
pharmacophor
model
gener
default
paramet
genet
algorithm
linear
assign
hypermolecular
align
databas
galahad
run
statist
valu
list
tabl
obtain
model
repres
differ
tradeoff
among
conflict
demand
maxim
steric
consensu
maxim
pharmacophor
consensu
minim
energi
twenti
model
pareto
rank
mean
one
model
superior
one
high
energi
recogn
highenergi
valu
due
steric
clash
small
valu
energi
high
valu
specif
nhit
steric
molqri
desir
best
model
therefor
consid
best
model
statist
valu
shown
tabl
model
contain
two
acceptor
atom
four
hydrophob
center
shown
figur
convert
queri
virtual
screen
studi
pharmacophor
model
consist
result
comfa
comsia
four
hydrophob
center
mean
center
b
c
ring
steroid
two
acceptor
atom
next
ring
ring
indic
hydrogen
bond
acceptor
atom
two
posit
enhanc
activ
figur
select
galahad
model
includ
two
acceptor
atom
green
four
hydrophob
center
cyan
sphere
size
indic
queri
toler
obtain
best
galahad
model
figur
convert
uniti
queri
screen
databas
flexibl
databas
search
option
implement
perform
virtual
screen
primari
filter
lipinski
rule
five
van
der
waal
bump
qfit
pharmacophor
match
queri
hit
compound
appli
reduc
dataset
screen
pharmacophor
queri
yield
six
hit
compound
met
specif
requir
valu
six
hit
compound
predict
use
obtain
comfa
comsia
model
chemic
structur
predict
activ
valu
hit
compound
list
tabl
among
hit
compound
compound
nci
nci
show
highpredict
valu
comfa
comsia
model
expect
design
potent
novel
sai
compound
compound
compound
compound
compound
compound
use
analysi
structur
bioactiv
valu
present
tabl
valu
use
deriv
qsar
model
valu
studi
compound
cover
interv
log
unit
whole
data
set
compound
divid
two
group
approxim
ratio
train
set
compound
test
set
compound
tabl
select
train
test
set
done
manual
low
moder
high
activ
compound
present
roughli
equal
proport
set
train
set
use
build
predict
model
test
set
use
valid
predict
abil
model
qsar
model
analys
calcul
visual
perform
use
sybyl
molecular
model
packag
tripo
inc
st
loui
mo
usa
instal
red
hat
linux
workstat
identif
bioactiv
conform
import
step
qsar
studi
among
inhibitor
crystal
structur
compound
bound
aromatas
avail
protein
data
bank
pdb
code
therefor
compound
extract
complex
chosen
defin
like
bind
conform
modifi
ad
hydrogen
atom
without
chang
conform
minim
follow
step
optim
steepest
descent
initi
optim
simplex
iter
use
tripo
forc
field
gasteigermarsili
charg
ii
optim
conjug
gradient
iii
optim
bfg
threedimension
structur
molecul
construct
compound
energi
minim
compound
perform
accord
procedur
present
studi
compound
use
templat
highest
activ
compound
align
basi
common
structur
shown
figur
align
train
test
compound
shown
figur
comfa
steric
field
calcul
use
lennardjon
potenti
electrostat
field
calcul
use
coulomb
potenti
calcul
comfa
field
cubic
lattic
grid
space
x
z
direct
creat
automat
sybyl
grid
pattern
extend
unit
direct
beyond
dimens
molecul
steric
electrostat
probeligand
interact
energi
calcul
use
sp
carbon
probe
atom
charg
distancedepend
dielectr
function
lattic
point
cutoff
energi
set
kcalmol
electrostat
contribut
ignor
lattic
point
maxim
steric
interact
comsia
five
differ
similar
field
steric
electrostat
hydrophob
hbd
hba
calcul
comsia
model
also
deriv
lattic
box
five
field
calcul
use
probe
charg
radiu
hydrophob
hydrogen
bond
properti
attenu
factor
gaussian
distancedepend
function
order
deriv
qsar
model
comfa
comsia
descriptor
use
independ
variabl
valu
depend
variabl
pl
method
crossvalid
leaveoneout
use
sybyl
determin
optim
number
compon
use
crossvalid
coeffici
q
r
cv
obtain
optim
number
compon
pl
analysi
perform
valid
column
filter
gener
final
model
train
set
obtain
final
noncrossvalid
correl
coeffici
r
ncv
measur
qualiti
model
predict
capabl
qsar
model
determin
predict
correl
r
pred
predict
activ
test
set
obtain
model
produc
train
set
pharmacophor
hypothesi
gener
use
galahad
modul
sybyl
oper
two
main
stage
ligand
align
intern
coordin
space
conform
produc
align
cartesian
space
featur
consid
develop
pharmacophor
model
includ
hbd
atom
hba
atom
hydrophob
charg
center
studi
eight
compound
shown
tabl
select
carri
pharmacophor
hypothesi
genet
algorithm
use
creat
conform
molecul
compound
select
gener
pharmacophor
hypothesi
highli
activ
structur
divers
aromatas
inhibitor
proven
import
target
treatment
estrogendepend
cancer
order
search
potent
sai
lower
side
effect
overcom
drug
resist
qsar
studi
pharmacophor
model
virtual
screen
perform
qsar
techniqu
comfa
comsia
appli
first
time
newsynthes
sai
obtain
model
show
good
statist
result
q
r
ncv
r
pred
comfa
q
r
ncv
r
pred
comsia
indic
model
good
qualiti
predict
abil
comfa
comsia
contour
map
show
proper
bulki
group
near
favor
activ
bulki
group
near
unfavor
hydrogen
bond
acceptor
atom
enhanc
bioactiv
addit
pharmacophor
model
deriv
eight
highli
activ
structur
divers
compound
use
galahad
obtain
best
pharmacophor
model
includ
two
acceptor
atom
four
hydrophob
center
use
queri
search
databas
six
hit
compound
obtain
screen
pharmacophor
queri
valu
predict
use
obtain
comfa
comsia
model
expect
design
potent
novel
sai
present
qsar
pharmacophor
model
virtual
screen
approach
provid
use
inform
design
synthes
potent
novel
sai
shown
seri
recent
public
respons
call
comprehens
review
userfriendli
publicli
access
webserv
repres
futur
direct
develop
practic
use
predict
model
method
demonstr
new
novel
find
shall
make
effort
futur
work
provid
webserv
approach
find
present
paper
